Re: RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease

in response to

RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease

imtesty

posted on Jan 24, 2018 09:41PM

Imtesty,

According to this post, I added it to the link library back in early October 2017. But I just checked and I don't see it there any longer. When Resverlogix updated their website, a lot of previous link library entries no longer worked. I may have accidentally deleted this RVX-297 paper in the clean up. I'll add it back now. For those not familiar with RVX-297, see the other messages in the thread I linked to.